CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Vascular surgeryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D011183 Postoperative Complications NIH 0.71

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study (Covid-VAS)

There is an urgent need to understand the outcomes of COVID-19 infected patients who undergo surgery, specially vascular surgery. Capturing real-world data and sharing Spanish national experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care. The global community has recognised that rapid dissemination and completion of studies in COVID-19 infected patients is a high priority, so we encourage all stakeholders (local investigators, ethics committees, IRBs) to work as quickly as possible to approve this project. This investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk. This study does not collect any patient identifiable information (including no dates) and data will not be analysed at hospital-level.

NCT04333693 Vascular Surgical Procedures COVID-19 Postoperative Complications Procedure: Vascular surgery
MeSH:Postoperative Complications

Primary Outcomes

Description: 30-days mortality after vascular surgery in patients with COVID-19 infection

Measure: 30-days mortality

Time: 30-days

Secondary Outcomes

Description: 7-days mortality after vascular surgery in patients with COVID-19 infection

Measure: 7-days mortality

Time: 7-days

Description: 30-days reoperation after vascular surgery in patients with COVID-19 infection

Measure: 30-days reoperation

Time: 30-days

Description: Postoperative ICU admission after vascular surgery in patients with COVID-19 infection

Measure: Postoperative ICU admission

Time: 30-days

Description: Postoperative respiratory failure after vascular surgery in patients with COVID-19 infection

Measure: Postoperative respiratory failure

Time: 30-days

Description: Postoperative acute respiratory distress syndrome (ARDS) after vascular surgery in patients with COVID-19 infection

Measure: Postoperative acute respiratory distress syndrome (ARDS)

Time: 30-days

Description: Postoperative sepsis after vascular surgery in patients with COVID-19 infection

Measure: Postoperative sepsis

Time: 30-days


No related HPO nodes (Using clinical trials)